X Congresso Nazionale CLEO – Roma 2017
Intervista a Michael Sofia Leggi l’intervista
Archivio dell'autore: admin
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Di seguito il link per scaricare l’articolo Linee guida EASL-EASD-EASO NAFLD 2016
International Approvals
Spiacenti, ma questo contenuto è riservato agli utenti registrati.
NAFLD and HCC
nafld and hcc
Update on pharmacotherapies for cholestatic liver disease
Chol Liv Dis Therapies-1
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
Sorry, but you do not have permission to view this content.
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study
Non sei autorizzato. Per visualizzare il contenuto di questa pagina devi prima registrarti.
HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production
Clicca il link per leggere l’articolo http://www.journal-of-hepatology.eu/article/S0168-8278(16)30751-6/fulltext
CLEO
PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C
Clicca il link per leggere l’articolo http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/12/news_detail_002659.jsp&mid=WC0b01ac058004d5c1